title: Nuclear export of the human cytomegalovirus tegument protein pp65 requires cyclin-dependent kinase activity and the Crm1 exporter.
abstract: We have previously shown that treatment of human cytomegalovirus-infected cells with the cyclin-dependent kinase (cdk) inhibitor roscovitine has significant effects on several stages of the virus life cycle depending on the time of addition (V. Sanchez, A. K. McElroy, J. Yen, S. Tamrakar, C. L. Clark, R. A. Schwartz, and D. H. Spector, J. Virol. 78:11219-11232, 2004; V. Sanchez and D. Spector, J. Virol. 80:5886-5896, 2006). In this report, we add to these findings by demonstrating alterations in the phosphorylation and localization of pp65 (UL83) in cells treated with roscovitine. We observed that inhibition of cdk activity causes the retention of pp65 within the nucleus at late times postinfection. At the same time, we observed a change in the phosphorylation pattern of the protein. Interestingly, mutation of potential cdk phosphorylation sites did not affect the ability of pp65 to localize to the nucleus or to relocalize to the cytoplasm late in infection. However, we found that the cytoplasmic accumulation of pp65 late in infection was sensitive to the Crm1 inhibitor leptomycin B.
authors: Department of Microbial and Molecular Pathogenesis, Texas A&M Health Science Center, College Station, TX 77843, USA.
authors: Veronica
authors: V
authors: Sanchez
authors: Jeffrey A
authors: JA
authors: Mahr
authors: Nicole I
authors: NI
authors: Orazio
authors: Deborah H
authors: DH
authors: Spector
mesh_terms: D021581:Active Transport, Cell Nucleus; D000998:Antiviral Agents / Q000494:pharmacology; D002467:Cell Nucleus / Q000378:metabolism; D018844:Cyclin-Dependent Kinases / Q000378:metabolism*; D003587:Cytomegalovirus; D003593:Cytoplasm / Q000378:metabolism; D004791:Enzyme Inhibitors / Q000494:pharmacology; D005231:Fatty Acids, Unsaturated / Q000494:pharmacology; D005347:Fibroblasts / Q000821:virology; D006801:Humans; D028884:Karyopherins / Q000378:metabolism*; D008856:Microscopy, Fluorescence; D009154:Mutation; D010750:Phosphoproteins / Q000737:chemistry / Q000378:metabolism*; D011687:Purines / Q000494:pharmacology; D018160:Receptors, Cytoplasmic and Nuclear / Q000378:metabolism*; D000077546:Roscovitine; D014763:Viral Matrix Proteins / Q000737:chemistry / Q000378:metabolism*; D000097606:Exportin 1 Protein
chemical_list: D000998:Antiviral Agents; D018844:Cyclin-Dependent Kinases; D004791:Enzyme Inhibitors; D005231:Fatty Acids, Unsaturated; D028884:Karyopherins; D010750:Phosphoproteins; D011687:Purines; D018160:Receptors, Cytoplasmic and Nuclear; D000077546:Roscovitine; D014763:Viral Matrix Proteins; D000097606:Exportin 1 Protein; C065418:cytomegalovirus matrix protein 65kDa; C038753:leptomycin B
references: Mol Cell Biol. 1996 Oct;16(10):5623-33
references: 8816475
references: J Gen Virol. 1996 Jun;77 ( Pt 6):1151-7
references: 8683200
references: J Virol. 1999 May;73(5):3800-9
references: 10196274
references: J Virol. 2005 Dec;79(24):15494-502
references: 16306620
references: J Virol. 2006 Jan;80(2):951-63
references: 16378997
references: J Virol. 2006 Apr;80(7):3541-8
references: 16537622
references: J Virol. 2006 Jun;80(11):5611-26
references: 16699042
references: J Virol. 2006 Jun;80(12):5886-96
references: 16731927
references: Curr Opin Microbiol. 2006 Aug;9(4):423-9
references: 16814597
references: Traffic. 2005 Mar;6(3):173-86
references: 15702986
references: J Mol Biol. 1999 Dec 17;294(5):1351-62
references: 10600390
references: J Virol. 2000 Jan;74(2):975-86
references: 10623760
references: J Virol. 2000 Apr;74(8):3842-51
references: 10729158
references: J Virol. 2000 May;74(9):4192-206
references: 10756032
references: J Virol. 2002 Mar;76(6):2973-89
references: 11861863
references: J Gen Virol. 2002 May;83(Pt 5):1005-12
references: 11961254
references: J Virol. 2003 Dec;77(24):13214-24
references: 14645578
references: J Virol. 2004 Feb;78(3):1488-502
references: 14722304
references: FEMS Microbiol Rev. 2004 Feb;28(1):59-77
references: 14975530
references: J Virol. 2004 Oct;78(20):11219-32
references: 15452241
references: J Virol. 1986 Sep;59(3):714-27
references: 3016333
references: Virology. 1990 Sep;178(1):6-14
references: 2167561
references: J Virol. 1995 Feb;69(2):1071-8
references: 7815485
references: J Virol. 1995 Oct;69(10):5959-68
references: 7666500
references: Virology. 1997 May 12;231(2):239-47
references: 9168886